Inovalon Holdings, Inc, a technology company, provides cloud-based platforms empowering data-driven healthcare. It operates the Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities.
Read More…
Industry, Sector and Symbol
Industry Data processing & preparation
Sub-IndustryN/A
SectorComputer and Technology
Phone301-809-4000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$527.68 million
Profitability
Miscellaneous
Employees2,499
Next Earnings Date2/19/2020 (Estimated)
OptionableOptionable
Inovalon (NASDAQ:INOV) Frequently Asked Questions
What is Inovalon's stock symbol?
Inovalon trades on the NASDAQ under the ticker symbol "INOV."
How were Inovalon's earnings last quarter?
Inovalon Holdings Inc (NASDAQ:INOV) released its quarterly earnings results on Wednesday, October, 30th. The technology company reported $0.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.12 by $0.03. The technology company had revenue of $166.50 million for the quarter, compared to analysts' expectations of $164.92 million. Inovalon had a negative net margin of 1.37% and a positive return on equity of 7.11%. The firm's revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period last year, the company earned $0.11 EPS. View Inovalon's Earnings History.
When is Inovalon's next earnings date?
What guidance has Inovalon issued on next quarter's earnings?
Inovalon issued an update on its FY20 earnings guidance on Wednesday, October, 30th. The company provided earnings per share (EPS) guidance of $0.57-$0.61 for the period, compared to the Thomson Reuters consensus estimate of $0.56. The company issued revenue guidance of $698-$718 million, compared to the consensus revenue estimate of $697.73 million.
What price target have analysts set for INOV?
5 brokers have issued 1-year price targets for Inovalon's stock. Their forecasts range from $12.00 to $22.00. On average, they expect Inovalon's stock price to reach $18.60 in the next twelve months. This suggests that the stock has a possible downside of 7.8%. View Analyst Price Targets for Inovalon.
What is the consensus analysts' recommendation for Inovalon?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inovalon.
Has Inovalon been receiving favorable news coverage?
News stories about INOV stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Inovalon earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave media headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Inovalon.
Are investors shorting Inovalon?
Inovalon saw a decrease in short interest in the month of December. As of December 13th, there was short interest totalling 7,930,000 shares, a decrease of 7.0% from the November 28th total of 8,530,000 shares. Based on an average daily volume of 527,700 shares, the days-to-cover ratio is currently 15.0 days. Currently, 11.4% of the shares of the stock are short sold. View Inovalon's Current Options Chain.
Who are some of Inovalon's key competitors?
Some companies that are related to Inovalon include StoneCo (STNE), PagSeguro Digital (PAGS), Zendesk (ZEN), Autohome (ATHM), DXC Technology (DXC), Proofpoint (PFPT), Pegasystems (PEGA), CHURCHILL CAP C/SH (CCC), Bilibili (BILI), Zynga (ZNGA), YY (YY), Globant (GLOB), Five9 (FIVN), CarGurus (CARG) and Corelogic (CLGX).
What other stocks do shareholders of Inovalon own?
Who are Inovalon's key executives?
Inovalon's management team includes the folowing people:
- Keith R. Dunleavy, CEO & Chairman (Age 50)
- Mr. Robert A. Wychulis, Pres (Age 64)
- Mr. John Michael Burgin, Chief Product Officer (Age 45)
- Mr. Jonathan R. Boldt, Chief Financial Officer (Age 34)
- Mr. Jason B. Capitel, Chief Operating Officer (Age 47)
When did Inovalon IPO?
(INOV) raised $500 million in an initial public offering on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.
Who are Inovalon's major shareholders?
Inovalon's stock is owned by many different of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (0.49%), Penn Davis Mcfarland Inc. (0.30%), California Public Employees Retirement System (0.11%), Campbell & CO Investment Adviser LLC (0.03%), We Are One Seven LLC (0.02%) and CWM Advisors LLC (0.01%). Company insiders that own Inovalon stock include Jason Capitel, Keith R Dunleavy and Lee D Roberts. View Institutional Ownership Trends for Inovalon.
Which institutional investors are selling Inovalon stock?
INOV stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Penn Davis Mcfarland Inc., We Are One Seven LLC and CWM Advisors LLC. View Insider Buying and Selling for Inovalon.
Which institutional investors are buying Inovalon stock?
INOV stock was purchased by a variety of institutional investors in the last quarter, including Campbell & CO Investment Adviser LLC, California Public Employees Retirement System and Zurcher Kantonalbank Zurich Cantonalbank . Company insiders that have bought Inovalon stock in the last two years include Jason Capitel, Keith R Dunleavy and Lee D Roberts. View Insider Buying and Selling for Inovalon.
How do I buy shares of Inovalon?
Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Inovalon's stock price today?
One share of INOV stock can currently be purchased for approximately $20.17.
How big of a company is Inovalon?
Inovalon has a market capitalization of $3.13 billion and generates $527.68 million in revenue each year. The technology company earns $-39,160,000.00 in net income (profit) each year or $0.18 on an earnings per share basis. Inovalon employs 2,499 workers across the globe.View Additional Information About Inovalon.
What is Inovalon's official website?
How can I contact Inovalon?
Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]
MarketBeat Community Rating for Inovalon (NASDAQ INOV)
MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote "Outperform" if you believe INOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days.
